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Abstract
OBJECTIVE—This study evaluated whether measures of waking or diurnal cortisol secretion, or 
self-reported psychological disturbances differed among police officers with a Period3 (PER3) 
clock gene length polymorphism.
METHODS—The cortisol awakening response was characterized via the area under the salivary 
cortisol curve with respect to the increase (AUCI) or total waking cortisol (AUCG). Diurnal 
cortisol measures included the slope of diurnal cortisol and the diurnal AUCG. Psychological 
disturbances were characterized using the Center for Epidemiologic Studies Depression Scale, 
Impact of Events Scale, and Life Events Scale.
RESULTS—Officers with a 4/5 or 5/5 genotype had higher awakening AUCG and greater diurnal 
cortisol AUCG levels compared to officers with the 4/4 genotype. Among those working more 
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afternoon or night shifts, waking AUCI and AUCG were greater among officers with a 4/5 or 5/5 
genotype compared to the 4/4 referents.
CONCLUSION—Cortisol secretion was modified among police officers with different PER3 
VNTR clock gene variants.
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INTRODUCTION
Clock genes are part of the body’s intrinsic timekeeping system. Their expression exhibits 
positive and negative transcription-translation feedback loops that help maintain tissue-
specific circadian rhythmicity (Cermakian & Boivin 2009; Yu & Weaver 2011). Clock 
genes have been described in the body’s central pacemaker, the suprachiasmatic nuclei 
(SCN) (Fu & Lee 2003; Okamura et al. 2010), and in most peripheral tissues and major 
organ systems (Hastings et al. 2007). Clock gene expression helps maintain ~24-hour 
cyclical variation in numerous physiological and cellular processes in a manner that is 
synchronized with ambient light-dark cycles, and dysregulation of clock genes can impact 
sleep-wake cycles, cardiovascular, digestive and endocrine systems, and mental state 
(Hastings et al. 2007; Kripke et al. 2009; Takeda & Maemura 2010; Landgraf et al. 2012). 
Clock genes also influence cell cycle control (e.g. cell proliferation, DNA repair, apoptosis) 
(Khapre et al. 2010), and disrupted clock gene expression may increase susceptibility to 
several chronic diseases including cancer (Huang et al. 2011).
A variable number tandem repeat (VNTR) sequence within the human Period3 (PER3) 
clock gene (rs57875989) codes for 4 or 5 copies of a 54-base pair length polymorphism. 
Phenotypic differences in various physiological or psychological measures have been 
described among those with the 4/4 or 5/5 genotype, Some investigators have reported that 
the 4/4 genotype may be associated with evening diurnal preference (Archer et al. 2003; 
Ellis et al. 2009) and greater heroin dependence (Zou et al. 2008), whereas others suggest 
that the 5/5 or combined 4/5+5/5 genotypes are associated with morning preference (Archer 
et al. 2003; Ellis et al. 2009), poorer cognitive performance after short-term (40-hr) sleep 
deprivation (Groeger et al. 2008), higher circulating concentrations of insulin-like growth 
factor-1 or interleukin-6 (Chu et al. 2008; Guess et al. 2009), earlier age of onset of bipolar 
disorder (Benedetti et al. 2008), a tendency for depressive symptoms (Guess et al. 2009), or 
increased odds of breast cancer primarily among premenopausal women (Zhu et al. 2005). 
However, associations among those with different PER3 VNTR genotypes have not been 
consistent. For example, several studies have found no association between PER3 VNTR 
genotypes and diurnal preference or breast cancer (Dai et al. 2010; Barclay et al. 2011; 
Osland et al. 2011). Individuals with the 5/5 PER3 VNTR had strong correlations between 
PER3 expression and the timing of peak cortisol or melatonin levels in blood, whereas those 
with the 4/4 genotype did not (Boivin et al. 2003; Archer et al. 2008). Thus, the PER3 
VNTR may serve as a marker of genetic susceptibility to the effects of sleep deprivation or 
circadian misalignment that can influence the timing of secretion of cortisol or melatonin, 
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two hormones with typically robust circadian rhythms (Dijk & Archer 2010). However, the 
functional consequences of this polymorphism in terms of adaptation to work schedule or 
work-related stress are not completely understood, particularly among shiftworkers.
Cortisol is a well-described adrenal steroid “stress hormone” (Henry 1992). Salivary cortisol 
typically increases by 40-75% upon awakening (cortisol awakening response), and then 
decreases throughout the day (except for a common post-prandial spike after the mid-day 
meal) (Kudielka et al. 2006; Fries et al. 2009). Daily cortisol rhythms are controlled by the 
SCN through efferent connections with neurons of the paraventricular nucleus and through 
hypothalamic-pituitary-adrenal (HPA) axis-independent alterations in ACTH 
(adrenocorticotropic hormone) sensitivity in the adrenal cortex (Nader et al. 2010). Stressful 
circumstances stimulate an increase in cortisol secretion (Kudielka et al. 2006). If these 
stressful circumstances become chronic in nature, they may result in an inability of the HPA 
axis to self-regulate cortisol, referred to as the “exhaustion stage” of the general adaptation 
syndrome, or allostatic overload (Motzer & Hertig 2004). The extent to which diurnal 
cortisol secretion patterns are influenced by polymorphic variation in clock genes is not well 
understood (Hastings et al. 2007; Archer et al. 2008; Nader et al. 2010). However, cortisol 
dysregulation can perturb physiological processes controlling inflammation (Elenkov 2008), 
and possibly augment susceptibility to depression, post-traumatic stress disorder, 
cardiovascular disease (CVD), type II diabetes, or stroke (Zuzewicz et al. 2000; Neylan et 
al. 2005; Huber et al. 2006; Gidron & Ronson 2008; Scheer et al. 2008). An altered pattern 
of circadian cortisol secretion also is associated with poor cancer survival (Sephton et al. 
2000; Sephton et al. 2012).
The Buffalo Cardio-Metabolic Occupational Police Stress (BCOPS) cohort study provides a 
prospective framework for examining biological processes through which stressors 
associated with police work may mediate adverse health outcomes. The protocol combines 
the characterization of stress biomarkers, subclinical CVD measures, psychosocial factors, 
and shiftwork to examine their potential associations with psychological disturbances and 
chronic diseases afflicting police officers (Violanti et al. 2006; Violanti et al. 2009). 
Shiftwork can result in circadian rhythm dysregulation, sleep insufficiency, and chronic 
stress (Shields 2002; Burch et al. 2009), which could eventually lead to cortisol 
dysregulation and allostatic overload (McEwen & Stellar 1993). Previously, we found that 
recent night work (within 3-14 days), or a high number of cumulative shift changes over a 
period of years was associated with reductions in the salivary cortisol awakening response 
among officers in this cohort (Wirth et al. 2011). The possible implications for cortisol 
dysregulation, or changes in the human stress response due to PER3 genetic variation among 
police or other workers in stressful occupations remains to be determined. Our objective in 
the present analysis was to test the hypotheses that police officers with a 4/5 or 5/5 PER3 
genotype have a more robust awakening (waking AUCI or AUCG) or diurnal cortisol rhythm 
(diurnal AUCG, slope) compared to those with the 4/4 genotype, and whether this 
relationship may be modified by shiftwork. Potential differences in depressive or stress-
related symptoms among those with different PER3 VNTR genotypes were also examined.
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METHODS
Study population
Police officers from the Buffalo, New York Police Department enrolled in the BCOPS 
cohort were selected using a computer-generated random sample (42 females, 58 males) 
(Violanti et al. 2006; Wirth et al. 2011). The study received Institutional Review Board 
approval and all subjects provided informed consent. Participants were examined at a health 
clinic on a scheduled training day or day off, and saliva collection occurred the day after the 
clinic visit at the officers’ homes. Data collection included a peripheral white blood cell 
sample for DNA recovery, serial saliva collection over a single non-work day, long-term 
shiftwork history, basic demographic characteristics, and the completion of several validated 
instruments that ascertained stress related to traumatic events (Impact of Events Scale or 
IES) (Horowitz et al. 1979), significant life events (Life Events Scale) (Paykel et al. 1971), 
or depressive symptoms (Center for Epidemiologic Studies Depression scale or CES-D) 
(Radloff 1977). A majority of the participating officers (88%) were either working a day 
shift or had a day off prior to their clinic visit.
Shiftwork history
Daily work histories were obtained for each participant from 1994 or initiation of 
employment (if it occurred after 1994) to the date of study examination between 2001 and 
2003 using electronic payroll records (Wirth et al. 2011). The typical work schedule after 
1994 consisted of four work days, four days off, four work days, three days off, and then the 
cycle was repeated. Long-term shiftwork variables included the cumulative number of shift 
changes and a categorical shift status variable defined as the shift on which each participant 
spent the majority of her or his time working during the study period. Shifts were classified 
based on start times as day (between 04:00-11:59 h), afternoon (between 12:00-19:59 h), or 
night (between 20:00-03:59 h). Most subjects (>85%) spent a majority (≥70%) of their total 
work time on their designated shift. This process of classifying officers into a shift status has 
shown good consistency summarized over 30, 60, or 90 days, and after 5 years of 
employment (Violanti et al. 2009; Wirth et al. 2011). Those on night or afternoon shifts 
were combined for the stratified analyses. Although officers worked fixed shifts during the 
study period (i.e., day, afternoon, or night only), they occasionally worked for an absent 
colleague or were temporarily assigned to a different shift schedule. The frequency of shift 
changes was defined as the number of times a participant switched between any two shift 
types during the study period.
Salivary cortisol
Salivary cortisol measurements are noninvasive, thereby reducing participant burden and 
facilitating protocol compliance; and the biologically active hormone can be readily 
quantified via a sensitive and specific immunoassay (Violanti et al. 2009). Participants 
collected serial saliva samples: upon first awakening, then at 15-, 30-, and 45-minute 
intervals after waking and at 12:00h (before lunch), 17:00h (before dinner), and at bedtime 
(Wirth et al. 2011). Cortisol levels obtained based on collection from time of awakening 
have a higher test-retest stability compared to samples collected at specific clock times 
(Coste et al. 1994; Pruessner et al. 1997; Neylan et al. 2005). On the morning of 
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participation, sample collection was achieved by placing a Salivette cotton roll (Sarstedt 
Aktiengesellschaft & Company, Numbrecht, Germany) into the mouth for three minutes to 
allow for saturation. The saturated roll was then refrigerated until delivery at the research 
laboratory for processing. Samples were shipped to the National Institute for Occupational 
Safety and Health (Toxicology and Molecular Biology Branch, Health Effects Laboratory, 
Morgantown, WV) where they were centrifuged and archived at −20 °C (Fekedulegn et al. 
2007). Cortisol determinations were performed at the Technical University of Dresden, 
Dresden, Germany, using a chemiluminescence immunoassay (CLIA, IBL-Hamburg, 
Germany) (Fekedulegn et al. 2007; Violanti et al. 2009; Wirth et al. 2011). Quality control 
samples were quantified at low and high concentrations for each assay plate, and analyses 
were repeated if control samples were outside the range of the expected concentration. The 
intra- and inter-assay coefficients of variation were 8% or below for either the high (25 
nmol/l) or low (3 nmol/l) control concentrations. Blind replicate samples of participants’ 
salivary cortisol (10%) had a coefficient of variation of 15%.
Waking cortisol was summarized using the area under the curve with respect to increase 
above baseline (i.e. first waking sample), and AUC above the assay detection limit or 
ground concentration (Fekedulegn et al. 2007). The AUCI represents the change in cortisol 
secretion after awakening, or its reactivity (Fekedulegn et al. 2007). If cortisol levels 
decrease relative to the first waking value, it is possible to obtain a negative AUCI value. 
The AUCG measures the total amount of cortisol secreted during the sampling period 
(Fekedulegn et al. 2007). The diurnal slope represents the change in cortisol secretion across 
the day, which was estimated by fitting the initial waking, noon, dinner, and bed time 
salivary cortisol sample concentrations to a linear equation and estimating the line of best fit 
(Kraemer et al. 2006; Heaney et al. 2012). All cortisol time points were required to calculate 
diurnal AUCG measures, but this requirement was not true for diurnal slope. To maintain 
consistency, we restricted all main diurnal analyses only to participants with both diurnal 
AUCG and diurnal cortisol slope measures.
Genotyping
Peripheral blood samples were collected on the day of the clinic visit, centrifuged using a 
Ficoll gradient to separate WBCs, then stored in capillary tubes at −80 °C for recovery of 
DNA. Genomic DNA was extracted using the DrGentle protocol (Takara, Japan) and DNA 
pellets (50-100 μg) were dissolved in 100-200 μL of TE buffer. About 200ng was subjected 
to polymerase chain reaction (PCR) using a Perkin Elmer GeneAmp System 9700 
(Waltham, MA) according to the manufacturer’s protocol. The PER3 VNTR repeat 
polymorphism was amplified using the following two primers: (forward) 5′-
CAAAATTTTATGACACTACCAGAATGGCTGAC-3′ and (reverse) 5′-
AACCTTGTACTTCCACATCAGTGCCTGG-3′ (Zhu et al. 2005). The PCR was 
performed in a reaction mixture of 25 μl containing standard PCR buffer, 5% DMSO, 1.0 
mM MgCl2, 0.2 mM dNTP, 1 unit Taq polymerase (Gibco-Invitrogen), and 0.4 μM of each 
oligonucleotide primer. The reactions were heated to 94 °C for 2 minutes followed by 35 
cycles of 94 °C for 30 seconds, 60 °C for 30 seconds, and 72 °C for 5 seconds. Reactions 
were extended for 7 minutes at 72 °C, and PCR products were then separated by 
electrophoresis on 3% agarose gel. Laboratory personnel were blinded to the identity and 
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characteristics of the participants. Quality control re-analyses of 10% of the genotypes 
indicated 100% concordance.
Statistical analysis
Analyses were performed using SAS analytical software package (version 9.2, Cary, NC)®. 
Relationships between each dependent variable (waking AUCI, waking AUCG, diurnal 
AUCG, diurnal slope, IES, CES-D, and Life Events Scale) and potential confounding factors 
(i.e. age, gender, race, education, marital status, rank, and years of police work) were 
evaluated univariately using the generalized linear models (PROC GLM) procedure in SAS. 
Variables were selected for further evaluation as potential confounders if their statistical 
significance was p≤0.15. A backward elimination procedure was then used to develop final 
models that included all variables that were statistically significant (p≤0.05) or, when 
removed from the model, changed the beta coefficient of the PER3 VNTR genotype by at 
least 10%. One diurnal AUCG observation was removed due to a studentized residual of 
4.02 and a Cook’s D of 0.48, which is greater than the suggested cut-point (4/sample size 
included in analysis [n=54] or 0.07). The GLM procedure in SAS was used to compute 
adjusted (least squares or LS) means of each dependant variable among those with different 
PER3 VNTR genotypes, after adjustment for the selected covariates. A square root 
transformation was used to obtain normally distributed values and normalized model 
residuals of the Life Events and CES-D scores; the LS means were back-transformed for 
presentation in the tables. A priori comparisons included differences in mean dependent 
variables among the 4/5, 5/5 or combined 4/5+5/5 genotypes compared to the 4/4 genotype. 
In separate analyses, differences in LS mean cortisol measures among the PER3 genotypes 
were stratified by shift status (night+afternoon vs. day shifts) or cumulative shift changes (a 
median split of <17 vs. >17). Individuals with 4/5 or 5/5 genotypes were similar with respect 
to all covariate and exposure variables, and were therefore combined in stratified analyses 
(Zhu et al. 2005; Dai et al. 2010). Ancillary logistic regression analyses indicated that 
participants with missing data did not differ with respect to the PER3 VNTR, shiftwork, 
CES-D, IES, Life Events Scale, or any covariate data, and were thus considered missing at 
random. Additional adjustment for time of awakening (first saliva collection) did not alter 
the interpretation of the results presented below.
RESULTS
Complete waking cortisol data were available for 57 officers (32 missing waking cortisol 
samples, 11 missing PER3 VNTR) and diurnal cortisol data were available for 54 
participants (37 missing diurnal cortisol, 9 missing PER3 VNTR). The distribution of PER3 
VNTR genotypes among participants was in Hardy-Weinberg Equilibrium (χ2=0, p-
value=1.0). The average number of years of police work in this population (± standard 
deviation) was 14±9 years (range: 1-33 years). The mean age was 43±8 years (range: 29-63 
years). Males comprised 60% of the study group and European Americans 75%. There were 
no statistically significant differences in age, gender, race, education, marital status, rank, 
years worked, or cumulative shift changes among the 4/5, 5/5, or 4/5+5/5 genotypes 
compared to the 4/4 group (Table 1). Similarly, there we no statistically significant 
differences in the mean time of first saliva sample collection among participants with the 
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4/4, 4/5 or 5/5 genotypes (08:16±112, 07:45±94, and 07:12±129 minutes, respectively) on 
the day of study participation.
Mean waking cortisol AUCG levels were greater among those with the 4/5+5/5 genotype 
(775 vs. 448 nmol/L-minute, p<0.01) compared to the 4/4 group. The 4/5 and 5/5 groups 
showed a tendency for higher waking AUCI values compared to the 4/4 group, although the 
differences were not statistically significant. The 4/5+5/5 group (7201 vs. 4996 nmol/L-
minute, p<0.01) and those with the 5/5 genotype (7279 vs. 4996 nmol/L-minute, p=0.02) 
had greater mean diurnal AUCG values compared to the 4/4 group (Table 2). Note that there 
were no differences between the 5/5 and 4/5 groups for any of the cortisol measures 
evaluated, which provides a reasonable rationale for combining 4/5 and 5/5 groups in the 
analysis. Only those with both a diurnal AUCG value and a diurnal slope were included in 
the analyses. A post-hoc analysis of all individuals with a diurnal slope value (n=76) did not 
change the interpretation of the results.
Regardless of shiftwork status, officers with the 4/5 or 5/5 genotype had greater mean 
diurnal AUCG values than officers with a 4/4 genotype (Table 3). After stratification by shift 
status, those participating in afternoon or night shiftwork who also possessed the 4/5+5/5 
genotype had elevated mean waking AUCI (202 vs. −8 nmol/L-minute, respectively, 
p=0.03) and mean waking AUCG values (791 vs. 361 nmol/L-minute, respectively, p=0.01) 
relative to shiftworkers with the 4/4 genotype (Table 3). However, these values did not 
differ by genotype among day workers. When cumulative shift changes were examined, 
officers with the 4/5 or 5/5 genotype tended to have greater mean waking AUCI, waking 
AUCG, or diurnal AUCG values compared to those with the 4/4 genotype, regardless of 
whether they were above or below the median number of cumulative shift changes (Table 
4). There were no statistically significant differences in the mean diurnal cortisol slopes 
(Tables 2-4) or mean scores for IES, Life Events Scale, or CES-D among those with 
different PER3 VNTR genotypes (Table 2).
DISCUSSION
The role of the PER3 length polymorphism in the regulation of sleep and circadian 
processes in human populations has not been fully elucidated. The extra copy of the 5-repeat 
PER3 VNTR sequence contains several potential casein kinase Iε (CKIε) phosphorylation 
motifs (Archer et al. 2003). Phosphorylation of Period clock genes by CKIε is required for 
translocation of the period and cryptochrome protein complex into the cell nucleus so that it 
can exert its influence on the negative arm of the clock gene transcriptional-translational 
feedback loop. CKIε also facilitates metabolic degradation of this complex (Nader et al. 
2010). In the PERIOD 2 clock gene, a CKIε binding site mutation has been associated with 
gene hypophosporylation and familial advanced sleep phase syndrome (Toh et al. 2001). 
Polymorphic variation in the PER3 gene has been associated with differences in the 
homeostatic regulation of sleep and the timing of circadian hormone secretion (Archer et al. 
2008; Dijk & Archer 2010). When participants with different PER3 VNTR genotypes were 
subjected to a 40-hour sleep deprivation protocol, those with the 5/5 genotype experienced 
greater changes in EEG activity and REM sleep, and increased sleep pressure compared to 
those with the 4/4 genotype (Cajochen et al. 1995; Dijk et al. 1997; Viola et al. 2007). 
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Individuals with this genotype also performed poorly (relative to baseline) on a waking 
performance test after sleep deprivation, whereas impacts among those with the 4/4 
genotype were much less apparent (Viola et al. 2007). Other studies suggest that PER3 may 
only have a minimal role in regulating circadian processes (Shearman et al. 2000; Bae et al. 
2001; Costa et al. 2011), and that the influence of the PER3 VNTR on sleep homeostasis 
may vary depending on the duration of sleep deprivation, or the strategy used to adjust to 
sleep loss (Goel et al. 2009; Gamble et al. 2011). Whether the PER3 VNTR evokes 
differences in circadian endocrine secretion, for example among shift workers or those with 
altered sleep-wake timing, remains to be determined. Positive correlations between PER3 
expression and the timing of peak melatonin or cortisol secretion (but not amplitude) were 
previously observed among those with the 5/5 genotype, whereas these measures were not 
well correlated among subjects with the 4/4 genotype (Archer et al. 2008) . Although no 
cause-effect relationship was established in that study, the results suggest that the 5/5 variant 
may facilitate coupling of cortisol secretion to the circadian system through PER3 
expression. In addition to its influence on the timing of cortisol secretion (Archer et al. 
2008), the PER3 VNTR has been associated with adverse health outcomes that might 
overlap with cortisol dysregulation, including delayed sleep phase syndrome (Ebisawa et al. 
2001), bipolar disorder (Dallaspezia et al. 2011), and increased cancer risk (Zhu et al. 2009; 
Dai et al. 2010). However, the functional consequences of this relationship remain to be 
determined.
Salivary cortisol values among officers participating in the present study were generally 
representative of those observed in other populations, with higher levels in the morning and 
declining values throughout the day (Kudielka et al. 2007; Griefahn & Robens 2008). 
Consistent with the hypothesis that the 5/5 genotype may be linked with circadian cortisol 
secretion, officers with a 4/5 or 5/5 genotype had an adjusted mean waking AUCI that was 
106% greater, a waking mean AUCG that was 73% greater, and mean cortisol output across 
the day that was 44% greater than those with a 4/4 genotype (Table 2). The reason that no 
difference in the mean diurnal cortisol slope was observed among those with different PER3 
genotypes is uncertain, but suggests that the PER3 VNTR had a stronger influence on 
morning cortisol secretion than secretion occurring throughout the day. The primary 
mechanism for cortisol’s robust circadian rhythm may be an increase in morning secretion 
due to enhanced light sensitivity occurring at that time of day (Clow et al. 2004). If so, then 
individuals with a morning circadian preference who typically exhibit earlier wake times 
would be expected to have an increased cortisol secretion due to an increased probability of 
elevated light exposure after awakening. This is consistent with studies that observed 
elevated cortisol levels among morning types compared to evening types (Bailey & 
Heitkemper 2001; Kudielka et al. 2006). Because the 5/5 PER3 genotype tends to be more 
frequently associated with morningness (Archer et al. 2003; Ellis et al. 2009), our findings 
are consistent with these observations. However, diurnal preference has not always been 
associated with the PER3 VNTR (Barclay et al. 2011; Osland et al. 2011), and chronotype 
was not characterized in this study. Nonetheless, we found that collection of the first saliva 
sample occurred about one hour earlier, on average, among those with the 5/5 genotype 
compared to the 4/4 genotype (08:16±112, 07:45±94, and 07:12±129 minutes for the 4/4, 
4/5 and 5/5 genotypes, respectively). Although these differences were not statistically 
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significant, it is possible that they contributed to the salivary cortisol measures that were 
observed.
The SCN synchronizes the circadian rhythms of ACTH and cortisol secretion, as well as 
clock gene expression within the pituitary gland and adrenal cortex (Dickmeis 2009; Girotti 
et al. 2009; Nader et al. 2010; Tonsfeldt & Chappell 2012). There are currently several 
models describing pathways whereby light-entrained SCN activity, in conjunction with 
neural and endocrine effectors of the HPA axis, regulate diurnal cortisol secretion. 
Although, the role of PER3 in these processes remains to be determined, one possibility is 
that PER3 may influence sensitivity of the circadian system to ambient light exposure. A 
genetic predisposition to light-induced suppression of melatonin, another hormone with a 
robust circadian rhythm, was recently observed among individuals with the 5/5 PER3 VNTR 
genotype, whereas 4/4 homozygotes were less responsive (Chellappa et al. 2012). Based on 
these observations, we speculate that light-induced morning cortisol secretion may occur in 
a similar, PER3 genotype-dependent manner.
Examination of cortisol and psychometric measures in conjunction with the PER3 VNTR 
among police officers in this study provided an opportunity to evaluate the influence of 
genotype and shiftwork on these parameters in a real-world setting. A strength of the 
BCOPS cohort is that long term shiftwork histories were quantified among participants via 
reconstruction of payroll records. We previously reported that officers working short-term 
night or afternoon shifts (3-14 days prior to saliva collection) had reduced waking cortisol 
AUCI or AUCG compared to day workers, consistent with several other studies among 
shiftworkers (Zuzewicz et al. 2000; Kudielka et al. 2007; Griefahn & Robens 2008). In 
addition, officers with more cumulative shift changes over periods of years also had reduced 
waking AUCI values (Wirth et al. 2011). Thus, we hypothesized that shiftwork may modify 
the relationship between the PER3 VNTR and cortisol secretion. When stratified by shift 
status, those with a 4/5 or 5/5 genotype who were working night or afternoon shifts had the 
highest waking AUCI values, more than double what was observed among day workers with 
the 4/5 or 5/5 genotype, which suggests a possible gene-environment interaction. Caution in 
the interpretation of these findings is warranted given the relatively limited sample size 
among strata of shiftwork and genotype. Also, results obtained for waking or diurnal AUCG 
indicated that, regardless of shift status, those with a 4/5 or 5/5 genotype had cortisol 
secretion patterns that were elevated compared to those with the 4/4 genotype. Overall, the 
results support the possibility that an extra PER3 VNTR copy enhances cortisol secretion. If 
this effect is modified by shiftwork, it most likely influences the absolute increase in cortisol 
after awakening (AUCI) rather than the total amount secreted after awakening (AUCG), or 
cortisol secretion throughout the day.
In the present study, the PER3 VNTR was not associated with stress-related psychological 
symptoms including depression or life events, in contrast with previous studies (Guess et al. 
2009; Dallaspezia et al. 2011). Only about 6% of officers were depressed based on the CES-
D definition (score ≥16), thus there may not have been enough variation in CES-D scores to 
determine differences between the PER3 VNTR genotypes. Stress or depressive symptoms 
were also a potential source of bias related to cortisol in this study since these symptoms can 
be associated with both cortisol secretion and the PER3 genotype (Chida & Steptoe 2009). 
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However, there was no change in the interpretation of the results when the cortisol analyses 
were adjusted for the effects of the Life Events Scale, CES-D, or IES. Although we adjusted 
for these and other important confounding factors, information on other covariates was 
unavailable, for example ambient light exposures (Sephton & Spiegel 2003; Clow et al. 
2004). Similarly, poor sleep or diets high in fat and low in fruit and vegetable intake may be 
associated with disrupted or flattened diurnal cortisol slopes (Kumari et al. 2011; Heaney et 
al. 2012). Thus, the possibility of residual confounding by these or other factors cannot be 
entirely eliminated.
In conclusion, the cross-sectional nature of this study precludes the ability to infer causation, 
although the results suggest that the 5-repeat sequence of the PER3 VNTR may facilitate 
increased cortisol secretion, particularly in the morning. Individuals with this genotype may 
be more susceptible to factors that can cause circadian rhythm disruption, such as shiftwork, 
poorly timed light exposures, or changes in sleep-wake timing. However, only modest 
evidence for a PER3-related influence of shiftwork on cortisol secretion was obtained in the 
present study. Cortisol dysregulation may have long-term health implications. Reduced 
cortisol secretion or a flattened slope has been associated with poor sleep quality (Backhaus 
et al. 2004), chronic fatigue syndrome and symptoms of burnout (Roberts et al. 2004), 
PTSD (Rohleder et al. 2004), depression (Stetler & Miller 2005), adverse cardiovascular 
health and mortality (Hurwitz Eller et al. 2001; Kumari et al. 2011), increased all-cause 
mortality (Kumari et al. 2011), and decreased breast or lung cancer survival (Sephton et al. 
2000; Sephton et al. 2012). Although linkages between circadian clock gene expression and 
the HPA axis have been identified, the pathological implications of dysregulation of these 
processes await further characterization (Nader et al. 2010; Mavroudis et al. 2012).
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Tab. 3
Mean Waking and Diurnal Cortisol (95% Confidence Intervals) by Shift Type and PER3 VNTR Genotype, 
BCOPS Study, Buffalo, NY, USA, 2001–2003.
Risk Factor 4/4 4/5 + 5/5 p-value 4/4 vs. 4/5 + 5/5
Waking AUCI
Shift Type
Day 126 (−14–267)
n=10
61 (−43–166)
n=18
0.46
Night + Afternoon –8 (–164–148)
n=9
202 (93–311)
n=17
0.03
p-value Day vs. Night + Afternoon 0.20 0.07
Waking AUCG
Shift Type
Day 512 (261–762)
n=10
736 (544–928)
n=18
0.16
Night + Afternoon 361 (52–670)
n=9
791 (573–1009)
n=17
0.01
p-value Day vs. Night + Afternoon 0.44 0.69
Diurnal AUCG
Shift Type
Day 4965 (3177–6753)
n=9
7120 (5900–8340)
n=17
0.04
Night + Afternoon 5003 (3222-6783)
n=9
7347 (6078-8615)
n=16
0.03
p-value Day vs. Night + Afternoon 0.98 0.79
Diurnal Slope
Shift Type
Day −0.0033 (−0.0044–−0.0021)
n=9
−0.0024 (−0.0032–−0.0015)
n=17
0.22
Night + Afternoon −0.0021 (−0.0034–−0.0007)
n=9
−0.0032 (−0.0041–−0.0023)
n=16
0.12
p-value Day vs. Night + Afternoon 0.21 0.19
Units for AUCI and AUCG are nmol/L-minutes. Abbreviations: AUCG – Area Under the Curve (Ground); AUCI – Area Under the Curve 
(Increase). Adjustments: Waking AUCG adjusted for rank; Waking AUCi adjusted for gender; Diurnal AUCG adjusted for education and age; 
Diurnal Slope adjusted for gender and age group.
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Tab. 4
Mean Waking and Diurnal Cortisol (95% Confidence Intervals) by Shift changes and PER3 VNTR Genotype, 
BCOPS Study, Buffalo, NY, USA, 2001–2003.
Risk Factor 4/4 4/5 + 5/5 p-value 4/4 vs. 4/5 + 5/5
Waking AUCI
Cumulative Shift Changes
<17 60 (−79–199)
n=12
123 (2–244)
n=15
0.50
≥17 68 (−110–247)
n=7
134 (28–241)
n=20
0.52
p-value <17 vs. ≥17 0.94 0.89
Waking AUCG
Cumulative Shift Changes
<17 430 (192–667)
n=12
877 (651–1104)
n=15
<0.01
≥17 494 (189–800)
n=7
708 (527–888)
n=20
0.22
p-value <17 vs. ≥17 0.73 0.22
Diurnal AUCG
Cumulative Shift Changes
<17 5,040 (3490–6590)
n=11
7,290 (5975–8604)
n=14
0.03
≥17 4,911 (3078–6745)
n=7
7,181 (6027–8335)
n=19
0.03
p-value <17 vs. ≥17 0.91 0.90
Diurnal Slope
Cumulative Shift Changes
<17 −0.0022 (−0.0033–−0.0011)
n=11
−0.0031 (−0.0041−–0.0021)
n=14
0.24
≥17 −0.0033 (−0.0046–−0.0019)
n=7
−0.0026 (−0.0034–−0.0017)
n=19
0.35
p-value <17 vs. ≥17 0.22 0.38
Shift change (from 1994 or initiation of employment until clinic examination in 2001), categories were based on a median split. Units for AUCI 
and AUCG are nmol/L-minutes. Abbreviations: AUCG – Area Under the Curve (Ground); AUCI – Area Under the Curve (Increase). Adjustments: 
Waking AUCG adjusted for rank; Waking AUCi adjusted for gender; Diurnal AUCG adjusted for education and age; Diurnal slope adjusted for 
gender and age group.
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